VAERS reports by lot

GSK DTaP/Tdap lot 7P5J5: VAERS reports

77 VAERS reports list lot 7P5J5 as a GSK DTaP/Tdap vaccine, received between 2020-11-20 and 2023-05-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
77
Reports
0%
Marked serious
0
With a death outcome
26
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3565%
General / Systemic (non-local)611%
Dermatological (non-injection-site)47%
Allergic / Anaphylactic36%
Gastrointestinal36%
Neurological24%
Cardiac / Cardiovascular12%

Where reports came from

U.S. state of the reporter, where given (top 12).

California7
Missouri6
Michigan6
Florida5
Illinois5
Washington5
Tennessee4
Texas4
North Carolina4
Colorado3
Ohio3
Oregon3

Reports by month received

2020-111
2020-121
2021-011
2021-021
2021-035
2021-047
2021-054
2021-067
2021-076
2021-083
2021-093
2021-103
2021-113
2021-123
2022-012
2022-026
2022-041
2022-052
2022-062
2022-071
2022-083
2022-091
2022-107
2022-121
2023-021
2023-052

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.